Aurora Cannabis Inc.
HealthcareNASDAQ:ACB · NASDAQ Global Select
-$0.04 today
Vol 0.86M · Avg 0.98M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-23.8%
avg -77.1%
ROIC
-30.2%
avg -14.1%
ROA
-20.3%
avg -43.3%
Analysis
ROA is currently the strongest return metric at -20.3% versus its period average of -43.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Miguel Martin | Chief Executive Officer & Executive Chairman | $2.28M | — | 53 | — | — |
Simona King | Chief Financial Officer | $862,566.00 | — | 54 | — | — |
Alex Miller | Executive Vice President of Operations & Supply Chain | $616,302.00 | — | — | — | — |
Nathalie Clark | Executive Vice President, General Counsel & Corporate Secretary | $585,531.00 | — | — | — | — |
Lori Schick | Executive Vice President of Human Resources | $580,617.00 | — | — | — | — |
Andre Jerome | Executive Vice President of Global Business Development | $500,928.00 | — | — | — | — |
David Aird | Executive Vice President of Information Technology | — | — | — | — | — |
Kerry Miller | Managing Director for Australia & New Zealand | — | — | — | — | — |
Rick Savone | Senior Vice President of Global Government Relations | — | — | — | — | — |
Michelle Lefler | Vice President of Communications & Public Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +48.9% (14yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +48.9% (14yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
BioAge Labs, Inc.
NASDAQ:BIOA
$679.20M
Ironwood Pharmaceuticals, Inc.
NASDAQ:IRWD
$600.84M
Aclaris Therapeutics, Inc.
NASDAQ:ACRS
$520.97M
Canopy Growth Corporation
NASDAQ:CGC
$425.84M
Editas Medicine, Inc.
NASDAQ:EDIT
$244.75M
LifeMD, Inc.
NASDAQ:LFMD
$227.30M
Alpha Teknova, Inc.
NASDAQ:TKNO
$225.18M
Lifecore Biomedical, Inc.
NASDAQ:LFCR
$211.55M
High Tide Inc.
NASDAQ:HITI
$203.04M
Organigram Global Inc.
NASDAQ:OGI
$149.22M
Who manages ACB?
Aurora Cannabis Inc. (ACB) lists 10 active executives. The top listed executive is David Aird, Executive Vice President of Information Technology.
Explore More
Continue the stock analysis
Jump to another research area for this company.